Search Results
Jun 01, 2026, 01:30 ET Unitree Announces H2 Plus, an NVIDIA Isaac GR00T Reference Humanoid Robot for Academic Research
development without rebuilding the same infrastructure for each robot or task.The NVIDIA Isaac GR00T developer platform will also support the Unitree G1 humanoid robot, extending the same development approach to a robot widely used by researchers and humanoid developers across leading institutions.AvailabilityUnitree
More news about: Unitree Robotics
Jun 01, 2026, 01:30 ET MSI Accelerates Enterprise AI Strategy with Cloud-to-Edge Ecosystem at COMPUTEX 2026
features an Intel® 13th Gen Core™ i Series (Raptor Lake-U) processor, supporting up to 32GB LPDDR5/LPDDR5X memory and 2TB PCIe SSD. Built to MIL-STD-810G standards with an IP65 rating, it survives 4-foot drops and functions from -10°C to 50°C. It offers a 650-nit sunlight-readable 11.6" display with glove/wet-touch
More news about: MSI
May 31, 2026, 23:51 ET Aphranel® MagiCCrystal CaHA Filler obtient la certification MDR de l'UE en tant qu'injectable régénérateur de première qualité
présentent une structure poreuse en forme de framboise conçue pour favoriser l'intégration des tissus et la régénération du collagène. Avec une valeur G' d'environ 5500 Pa, le matériau offre une stabilité à l'injection tout en conservant une biodégradation progressive.Le matériau ne contient pas
More news about: SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD; Aphranel
May 31, 2026, 23:50 ET Aphranel® MagiCCrystal CaHA Filler erhält die EU MDR-Zertifizierung als hochwertiges regeneratives Injektionsmittel
30–35 μm groß und weisen eine himbeerförmige poröse Struktur auf, die die Gewebsintegration und Kollagenregeneration unterstützen soll. Mit einem G'-Wert von etwa 5500 Pa bietet das Material Injektionsstabilität bei gleichzeitiger allmählicher biologischer Zersetzung.Das Material enthält keine
More news about: SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD; Aphranel
May 31, 2026, 23:00 ET Supermicro Launches New Server Solutions with Intel Xeon 6+ Processors to Reduce TCO and Accelerate Time-to-Online for Large-Scale Cloud and Data Centers
virtualization, 5G analytics, content delivery, and throughput-intensive workloadsSAN JOSE, Calif. and TAIPEI, June 1, 2026 /PRNewswire/ -- Super Micro Computer, Inc (NASDAQ: SMCI), an AI, Enterprise, Storage, 5G/Edge total
More news about: Super Micro Computer, Inc.
May 31, 2026, 23:00 ET Supermicro Launches New Server Solutions with Intel Xeon 6+ Processors to Reduce TCO and Accelerate Time-to-Online for Large-Scale Cloud and Data Centers
virtualization, 5G analytics, content delivery, and throughput-intensive workloadsSAN JOSE, Calif. and TAIPEI, May 31, 2026 /PRNewswire/ -- Super Micro Computer, Inc (NASDAQ: SMCI), an AI, Enterprise, Storage, 5G/Edge total
More news about: Super Micro Computer, Inc.
May 31, 2026, 22:38 ET Changingtek Robotics Launches High-Precision Tactile Sensing Data Collection Hand, Uhand
communication protocols of all Changingtek grippers, the tactile hand generates real-world sensing data with minimal deviation.Weighing merely 600 g and offering up to four hours of battery runtime, this portable hardware allows extended field deployment. It closes the full data loop required for embodied
More news about: Changingtek Robotics Technology (suzhou) Co., Ltd.
May 31, 2026, 22:15 ET 威強電 (IEI) 於 2026 COMPUTEX 展出強韌邊緣 AI 平台：推動 AI 在工業應用的落地部署
高效能運算與 AI 推論能力： 專為處理邊緣端高負載 AI 任務所打造，涵蓋多元的工業應用場景。展出產品包含針對大型語言模型 (LLM) 與視覺 AI 最佳化的邊緣 AI 伺服器 (GAIA-5040A)、具備 100G 高速網路傳輸的邊緣 AI 伺服器 (PUZZLE-9070)，以及工業級緊湊型系統 (GAIA-NAGX/NNX、
More news about: IEI Integration Corp.
May 31, 2026, 22:12 ET IEI Showcases Resilient Edge AI Platforms at COMPUTEX 2026: Advancing AI Deployment Across Industrial Applications
lineup spans diverse industrial scenarios. It includes Edge AI Servers optimized for LLM and vision AI workloads (GAIA-5040A), Edge AI server with 100G high-speed networking capability (PUZZLE-9070), and industrial-grade compact systems (GAIA-NAGX/NNX,
More news about: IEI Integration Corp.
May 31, 2026, 22:12 ET IEI Showcases Resilient Edge AI Platforms at COMPUTEX 2026: Advancing AI Deployment Across Industrial Applications
lineup spans diverse industrial scenarios. It includes Edge AI Servers optimized for LLM and vision AI workloads (GAIA-5040A), Edge AI server with 100G high-speed networking capability (PUZZLE-9070), and industrial-grade compact systems (GAIA-NAGX/NNX,
More news about: IEI Integration Corp.
May 31, 2026, 22:00 ET Changingtek Robotics Launches High-Precision Tactile Sensing Data Collection Hand, Uhand
communication protocols of all Changingtek grippers, the tactile hand generates real-world sensing data with minimal deviation.Weighing merely 600 g and offering up to four hours of battery runtime, this portable hardware allows extended field deployment. It closes the full data loop required for embodied
More news about: Changingtek Robotics Technology (suzhou) Co., Ltd.
May 31, 2026, 20:15 ET Long-term Follow-up Results of CARsgen's Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting
gastric/gastroesophageal junction adenocarcinoma (G/GEJA) and pancreatic cancer (PC).The Center for Drug Evaluation (CDE) of National Medical Products Administration (NMPA) of China has accepted the New Drug Application (NDA) for satri-cel for the treatment of Claudin18.2-positive advanced G/GEJA in patients who have
More news about: CARsgen Therapeutics
May 31, 2026, 20:00 ET 德昇濟醫藥在ASCO 2026公布Elisrasib（D3S-001）一線治療數據；新一代KRAS G12C抑制劑在初治NSCLC中展現裡程碑式療效
抑制劑，旨在實現快速、充分且選擇性的靶點結合。該藥物可與 KRAS G12C 的 GDP 結合（OFF）構象發生共價結合，從而有效阻斷核甘酸循環並抑制致癌信號通路。臨床前研究顯示其具有強效活性，在臨床相關暴露水平下可實現完全的 KRAS G12C 靶點占領，並具備中樞神經系統（CNS）滲透能力。Elisrasib 目前正在全球范圍內開展 II 期單藥及聯合治療研究，覆蓋 KRAS G12C 突變實體瘤（包括 NSCLC、結直腸癌（CRC) 、胰腺癌（PDAC) 等。）關於德昇濟醫藥德昇濟醫藥是一家全球性生物技術公司，專注於具有「同類首創」或「同類最佳」潛力的腫瘤及免疫疾病創新療法的發現、開發及注冊。公司依托深厚的臨床洞察與生物標志物驅動策略，持續推進針對關鍵致癌驅動因子及免疫通路的產品管線佈局，並擁有所有在研項目的全球權益。如需了解更多信息，請訪問：
More news about: 德昇濟醫藥（D3 Bio）
May 31, 2026, 20:00 ET D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLC
in combination with pembrolizumab from an ongoing Phase I/II study of elisrasib (D3S-001), its next-generation KRAS G12C inhibitor, in patients with KRAS G12C mutation–positive (G12Cmut) non–small cell lung cancer (NSCLC). The data were presented in a Clinical Science Symposium at the 2026 American Society
More news about: D3 Bio
May 31, 2026, 17:36 ET Servier to Present Extended Follow-Up Results from the Phase 3 INDIGO Trial Showing Durable and Sustained Treatment Benefits of VORANIGO® (vorasidenib) at ASCO 2026
https://doi.org/10.1056/nejmoa2304194 2. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021 Aug 2;23(8):1231-1251.
More news about: Servier Pharmaceuticals
May 31, 2026, 08:29 ET RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited
chemotherapy: pivotal results from the phase 1b/2 OrigAMI-4 study. Epub May 31, 2026. doi:10.1200/JCO-26-01042.3 Zebralla V, Wichmann G, Pirlich M, et al. Dysphagia, voice problems, and pain in head and neck cancer patients. Eur Arch Otorhinolaryngol. 2021;278(10):3985-3994. doi:10.1007/s00405-020-06584-6
More news about: Johnson & Johnson
May 31, 2026, 08:27 ET Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradigm
https://www.cancer.org/cancer/types/prostate-cancer/about/key-statistics.html 12 Napodano G, Ferro M, Sanseverino R. High-risk prostate cancer: A very challenging disease in the field of uro-oncology. Diagnostics (Basel). 202126;11(3):400.
More news about: Johnson & Johnson
May 29, 2026, 16:30 ET AT&T to Release Second-Quarter 2026 Earnings on July 22
families, friends and neighbors, plus nearly 2.5 million businesses, connect to greater possibility. From the first phone call 150 years ago to our 5G wireless and multi-gig internet offerings today, we @ATT innovate to improve lives. For more information about AT&T Inc. (NYSE:T), please visit us
More news about: AT&T
May 29, 2026, 14:00 ET RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) demonstrates prolonged clinical benefit as a first-line treatment for atypical EGFR-mutated non-small cell lung cancer
EGFR-mutated advanced NSCLC, excluding EGFR exon 20 insertion mutations (n=49). The most common atypical EGFR mutations included G719X (55 percent), S768X (27 percent) and L861X (24 percent), with 35 percent of patients harboring multiple atypical mutations. The study
More news about: Johnson & Johnson
May 29, 2026, 12:28 ET Lupin Receives Approval from U.S. FDA for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets
Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets, 1.479 g/0.225 g/0.188 g is bioequivalent to the reference listed drug (RLD), Sutab® Tablets, 1.479 g/0.225 g/0.188 g of Azurity Pharmaceuticals, Inc. Lupin is the exclusive first-to-file for this product and is eligible
More news about: Lupin Pharmaceuticals, Inc.
May 29, 2026, 12:00 ET Sportradar Group AG (SRAD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
SPORTRADAR GROUP AG (SRAD), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE JULY 17, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at
More news about: Law Offices of Howard G. Smith
May 29, 2026, 12:00 ET Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BIOSCIENCE HOLDINGS LIMITED (RGC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE JUNE 23, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at
More news about: Law Offices of Howard G. Smith
May 29, 2026, 10:15 ET OpenText Among First Canadian Companies to Join OECD Global Safe AI Reporting Framework
Hiroshima AI Process (HAIP) Reporting Framework, the international mechanism where organizations demonstrate alignment with the G7's voluntary code of conduct for the safe development and deployment of advanced AI.
More news about: Open Text Corporation
May 29, 2026, 10:15 ET OpenText Among First Canadian Companies to Join OECD Global Safe AI Reporting Framework
Hiroshima AI Process (HAIP) Reporting Framework, the international mechanism where organizations demonstrate alignment with the G7's voluntary code of conduct for the safe development and deployment of advanced AI.
More news about: Open Text Corporation
May 29, 2026, 09:48 ET A Microcap Just Staked a Claim in the AI Agent Security Land Grab
Issued on behalf of Integrated Cyber Solutions Inc. dba Integrated Quantum Technologies (CSE: ICS) (OTCQB: IGCRF) (FSE: Y4G)As enterprises rush to deploy autonomous AI agents, a new security problem is emerging that the old cybersecurity playbook wasn't built for —
More news about: USA News Group